OLD Category: pan cancer panels

Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast Cancers

• O'Meara T, Marczyk M, Qing T, Yaghoobi V, Blenman K, Cole K, Pelekanou V, Rimm DL, Pusztai L

RNA from stabilized whole blood enables more comprehensive immune gene expression profiling compared to RNA from peripheral blood mononuclear cells

• van der Sijde F, Li Y, Schraauwen R, de Koning W, van Eijck CHJ, Mustafa DAM

High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot

• Keam SP, Halse H, Nguyen T...Haupt Y, Williams SG, Neeson PJ

CD200 promotes immunosuppression in the pancreatic tumor microenvironment

• Choueiry F, Torok M, Shakya R...Bai XF, Carson III WE, Mace TA

Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer

• Marks DK, Gartrell RD, El Asmar M...Connolly E, Saenger Y, Kalinsky K

Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors

• Albershardt TC, Leleux J, Parsons AJ, Krull JE, Berglund P, ter Meulen J

Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES Switch

• Tu WJ, McCuaig RD, Tan AHY...Prasanna T, Milburn P, Rao S

Gene-Environment Regulation of Chamber-Specific Maturation during Hypoxemic Perinatal Circulatory Transition

• Zhao Y, Kang X, Barsegian A...Van Arsdell G, Nelson SF, Touma M

Differences in immune-related gene expressions and tumor-infiltrating lymphocytes according to chemotherapeutic response in ovarian high-grade serous carcinoma

• Choi KU, Kim A, Kim JY, Kim KH, Hwang C, Lee SJ, Park WY, Jung S, Choi HJ, Kim K.

Nectin-2 expression on malignant plasma cells is associated with better response to TIGIT blockade in multiple myeloma

• Lozano E, Mena MP, Díaz T, Prat A, Rosinol L, Fernández de Larrea C

DNA hypomethylation promotes transposable element expression and activation of immune signaling in renal cell cancer

• de Cubas AA, Dunker W, Zaninovich A...Ganesan S, Karijolich J, Rathmell WK

First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients

• Kim ST, Hong JY, Park SH, Nam DH, Lee JW, Park K, Kim KM, Lee J